STOCK TITAN

OrthoPediatrics corp - KIDS STOCK NEWS

Welcome to our dedicated news page for OrthoPediatrics (Ticker: KIDS), a resource for investors and traders seeking the latest updates and insights on OrthoPediatrics.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect OrthoPediatrics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of OrthoPediatrics's position in the market.

Rhea-AI Summary
OrthoPediatrics Corp. (Nasdaq: KIDS) increases its support of IPOS as an Emerald-Level sponsor, showcasing its expanding product portfolio at the event. Over 500 pediatric orthopedic surgeons are registered to attend the meeting from December 5-9, in Orlando, Florida. The company aims to connect with its surgeon customers and continue to partner with them in education, emphasizing its commitment to advancing the field of pediatric orthopedics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.77%
Tags
conferences
-
Rhea-AI Summary
OrthoPediatrics Corp. (NASDAQ: KIDS) announces participation in fireside chats at Stifel 2023 Healthcare Conference and Piper Sandler 35th Annual Healthcare Conference. The company's President & CEO and COO/CFO will discuss at the events, with audio webcasts and replays available online at the OrthoPediatrics investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
conferences
-
Rhea-AI Summary
OrthoPediatrics Corp. reported record-setting quarterly revenue of $40.0 million, a 14% increase compared to the same period last year. The company helped over 22,000 children in Q3 2023, bringing the total to over 692,000 since inception. Adjusted EBITDA reached $3.6 million, up from $1.9 million in Q3 2022. OrthoPediatrics launched new products, including the Pediatric Nailing Platform TIBIA system and the DF2 Brace. The company reiterated its full-year 2023 revenue guidance of $148.0 million to $151.0 million, representing 21% to 23% growth compared to the prior year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.19%
Tags
Rhea-AI Summary
OrthoPediatrics Corp. has entered into an exclusive Distribution Agreement with Ora Medical to sell The Levity, a gait trainer for children with walking difficulties. The device features a personalized treatment, adjustable features, and a foldable design. The partnership aims to improve the mobility of children globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.01%
Tags
none
-
Rhea-AI Summary
OrthoPediatrics Corp. has announced the limited release of the Mitchell Ponseti Plus Bar (MP+) as part of their Specialty Bracing portfolio for kids with clubfoot. The new MP+ Bar features several innovations and enhancements compared to their traditional Bar. The company is also developing the MP Lite boots & bar system for markets outside the United States. OrthoPediatrics plans to continue launching new innovative products to address the large unmet needs in the pediatric orthopedic market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.7%
Tags
none
-
Rhea-AI Summary
OrthoPediatrics Corp. announces the release of the Pediatric Nailing Platform TIBIA system and successful completion of the first cases.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.55%
Tags
none
Rhea-AI Summary
OrthoPediatrics Corp. to release third quarter 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.67%
Tags
conferences earnings
-
Rhea-AI Summary
OrthoPediatrics Corp. announces strategic partnership with Children’s National Hospital for pediatric device innovation
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.69%
Tags
none
-
Rhea-AI Summary
OrthoPediatrics Corp. announces limited release of DF2® Brace for treating pediatric femur fractures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
none
Rhea-AI Summary
OrthoPediatrics Corp. sponsored the 58th Annual Meeting for the Scoliosis Research Society, showcasing the ApiFix technology for treating Adolescent Idiopathic Scoliosis. The company highlighted its commitment to pediatric orthopedic patients and non-fusion technologies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.64%
Tags
none
OrthoPediatrics corp

Nasdaq:KIDS

KIDS Rankings

KIDS Stock Data

739.51M
16.04M
31.87%
71.2%
4.41%
Ophthalmic Goods Manufacturing
Manufacturing
Link
US
Warsaw

About KIDS

orthopediatrics is the worldwide leader in pediatric orthopedics. we are the first company whose total focus is helping children with orthopaedic conditions and injuries by providing the surgeons who care for them with anatomically appropriate implants. every day, we focus purely on advancing the field of pediatric orthopedics through the innovative development of state-of-the-art technologies, commitment to quality products, and industry-leading support and clinical education with our experienced team of experts. our offering is continuing to expand as we strive to develop all of the necessary implants and instruments that a pediatric orthopedic surgeon needs to treat his/her patients, including: long bone deformity correction & trauma, spine, and sports medicine. as we continue to grow, we are looking for talented professionals to join our cause! visit our website to learn more about current openings, or submit a resume to careers@orthopediatrics.com!